Renatus Tactical Acquisition I - Class A (RTAC) closed at $10.49 on November 13, 2026, up 0.1% from the previous close, on volume of 56,350 shares (30-day average 190,396).
Data as of November 13, 2026.
No headlines found.
Complete Genomics Appoints Lauren Selig to Board of Directors
Business Wire (Wed, 19-Aug 9:00 AM ET)
Renatus Tactical Acquisition Corp I is a blank check company.
Renatus Tactical Acquisition I - Class A trades on the NASDAQ stock market under the symbol RTAC.
As of November 13, 2026, RTAC stock price climbed to $10.49 with 56,350 million shares trading.
RTAC has a beta of 0.20, meaning it tends to be less sensitive to market movements. RTAC has a correlation of 0.15 to the broad based SPY ETF.
RTAC has a market cap of $326.88 million. This is considered a Small Cap stock.
RTAC has underperformed the market in the last year with a return of -5.0%, while SPY returned +13.4%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in RTAC shares. However, RTAC has outperformed the market in the last 3 month and 2 week periods, returning +0.4% and +0.1%, while SPY returned -2.8% and -0.2%, respectively. This indicates RTAC has been having a stronger performance recently.
RTAC support price is $10.46 and resistance is $10.50 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RTAC shares will trade within this expected range on the day.
